Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC - Vrije Universiteit Amsterdam Home
Help & FAQ
Home
Profiles
Research Units
Research output
Datasets
Prizes
Activities
Press / Media
Impacts
Search by expertise, name or affiliation
Are anti-EGFR monoclonal antibodies the magic bullets that remove circulating tumor cells in patients with non-small cell lung cancer (NSCLC)?
van Egmond, Marjolein
(Recipient)
Molecular cell biology and Immunology
Surgery
CCA - Cancer biology and immunology
CCA - Imaging and biomarkers
CCA - Treatment and quality of life
AII - Inflammatory diseases
Prize
Description
(€175.000).
Awarded date
2018
Degree of recognition
National
Granting Organisations
Koningin Wilhelmina Fonds (KWF)